Monitoring and pharmacokinetics of midazolam by patients with COVID-19 receiving respirator and ECMO therapy.
2021/41/N/NZ6/03856
Keywords
Descriptors
- NZ6_008: Inne zagadnienia pokrewne
- NZ5_007: Leczenie chorób człowieka
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Zabrzu
Voivodeship: śląskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 20 – announced on 2021-03-15
- Amount awarded
- 167 372 PLN
- Project start date
- 2022-02-21
- Project end date
- 2026-02-20
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.